Provention Bio, Inc.
PRVBDelisted Apr 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001695357
Provention Bio, Inc. was delisted on Apr 27, 2023; its insiders filed their last Form 4 on Apr 28, 2023; 183 institutions reported holding it in 13F filings for Q1 2023, worth $1.47B in total; Fairfax Financial was the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding Provention Bio, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 1 | 0 | −1 |
| Shares | 116.3K | 0 | −116.3K (−100.0%) |
| Value | $2.80M | $0 | −$2.80M (−100.0%) |
New holders (0)
Institutions that held Provention Bio, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
None.
Sold out (1)
Institutions that held Provention Bio, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| UBS Asset Management Americas Inc | 116,324 | $2.80M |